Please assess the completion status of the following clinical trial:

Trial Title: Oral Contraceptives and Body Mass Index

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-35~* BMI \> 30kg/m2~* Proof of a normal breast and pelvic exam within last 9 months~* Self reported normal menstrual periods (24-35 days)~* Good general health~* In the investigator's opinion, are subject's veins suitable the repeat blood draws dictated by study protocol~* Single progesterone level during screening visit ≥ 3ng/mL~* Hematocrit ≥ 36%~Exclusion Criteria:~* Contradictions to COCs (history of deep vein thrombosis,myocardial infection, uncontrolled hypertension, pulmonary embolus, diabetes with vascular changes, stroke, migraines with neurologic changes, breast cancer, impaired liver function, uncontrolled thyroid disease, hypersensitivity or allergy to birth control)~* Smoker (must smoke 0 cigarettes)~* Actively seeking/involved in a weight loss program~* Currently pregnant/seeking pregnancy in the next 6 months~* Currently breast-feeding~* Past or current diagnosis of polycystic ovarian disease~* Recent use of birth control (Depot medroxyprogesterone: 6 months, Progestin implants: 6 months, Oral contraceptives, patch or ring: 2 months, Hormone impregnated IUD: 6 months)~* Currently taking medication that interferes with COC's (Rifampin, Carbamazepine, St. John's Wort)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- All participants (Type: OTHER): A low dose oral contraceptive given cyclically (21 days of active pills/cycle with a 7 day hormonal-free interval) for 2 cycles (56 days).
- Aviane and Portia (Type: ACTIVE_COMPARATOR): A low dose oral contraceptive given cyclically (30mcg EE component, 21 days of active pills/cycle with a 7 day hormonal-free interval) for two cycles
- Aviane & Aviane (Type: ACTIVE_COMPARATOR): A very-low dose oral contraceptive given continuously for 56 days (20mcg EE component, 28 days of active pills/cycle with no hormone free interval)

Based on this trial design, predict the completion outcome and termination type (if applicable).